Literature DB >> 10673399

Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells.

H Mühl1, H Kämpfer, M Bosmann, S Frank, H Radeke, J Pfeilschifter.   

Abstract

Interleukin-18 (IL-18) binding protein is a soluble decoy receptor for IL-18 which efficiently antagonizes biological functions of IL-18 in vitro and in vivo. Since regulation of IL-18 activity likely contributes to the pathogenesis of inflammatory diseases as well as malignancies, we investigated gene expression of IL-18 binding protein (IL-18BP) in different human cell systems, namely in the keratinocyte cell line HaCaT, in the colon carcinoma cell line DLD-1, and in primary renal mesangial cells. In unstimulated cells only minute amounts of mRNA coding for IL-18 binding protein were detectable. However, in all three cell types gene expression was markedly upregulated by interferon-gamma (IFN-gamma). IL-18 is recognized as a pivotal mediator of IFN-gamma production. Therefore, the present data imply that activity of IL-18 is modulated by a negative feedback mechanism which is mediated by IFN-gamma-induced IL-18 binding protein. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673399     DOI: 10.1006/bbrc.1999.2064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1-NF-κB-c-jun complex.

Authors:  Hubert Marotte; Pei-Suen Tsou; Bradley J Rabquer; Adam J Pinney; Tatiana Fedorova; Nalin Lalwani; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-11

2.  Normal free interleukin-18 (IL-18) plasma levels in dengue virus infection and the need to measure both total IL-18 and IL-18 binding protein levels.

Authors:  Meta Michels; Quirijn de Mast; Mihai G Netea; Leo A Joosten; Charles A Dinarello; Pandji I F Rudiman; Sylvia Sinarta; Rudi Wisaksana; Bachti Alisjahbana; André J A M van der Ven
Journal:  Clin Vaccine Immunol       Date:  2015-04-15

3.  Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit.

Authors:  Xiangzhi Meng; Michael Leman; Yan Xiang
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

4.  Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Authors:  Kazutoshi Fujita; Charles M Ewing; William B Isaacs; Christian P Pavlovich
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

5.  The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta.

Authors:  Vladimir Hurgin; Daniela Novick; Menachem Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

6.  Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.

Authors:  Zhijie Wu; Valentina Giudice; Jichun Chen; Wanling Sun; Zenghua Lin; Keyvan Keyvanfar; Nidhi Talasani; Sachiko Kajigaya; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-10-12       Impact factor: 3.084

7.  Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients.

Authors:  Dawei Hu; Xiaoqian Liu; Shunle Chen; Chunde Bao
Journal:  Clin Rheumatol       Date:  2010-02-08       Impact factor: 2.980

8.  Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

Authors:  A Kaser; D Novick; M Rubinstein; B Siegmund; B Enrich; R O Koch; W Vogel; S H Kim; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 9.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22

10.  Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.

Authors:  Tomohiro Hori; Hidenori Ohnishi; Takahide Teramoto; Kohji Tsubouchi; Takafumi Naiki; Yoshinobu Hirose; Osamu Ohara; Mariko Seishima; Hideo Kaneko; Toshiyuki Fukao; Naomi Kondo
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.